Introduction. Introduction 2/18/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life

Size: px
Start display at page:

Download "Introduction. Introduction 2/18/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life"

Transcription

1 Introduction Vascular Access complications: Ultrasound Evaluation of the Mature AVF and Process Improvement High associated morbi-mortality Worsened quality of life Up to 25 % hospitalized Jose Ibeas M.D., Ph.D. Nephrology Department Parc Tauli Sabadell, Hospital Universitari Barcelona, Spain Costs Problems of Vascular Access: Creation: Introduction Resources: Radiological: Mapping Surgical: Mapping, Creation or Reconstruction Waiting lists Follow up: Need surveillanceprotocols Flow? Image? Treatment (Preventive) Interventionist Surgical Waiting lists Multidisciplinary requirement (Figure of Coordinator) Surveillance advised! ASDIN

2 Stenosis diagnosis capability (III): Δ Qa > 25%: S: 80% and VPP:89% Qa 500 ml/min + Δ Qa > 25%: S and VPP SIMILAR to ONLY SURVEILLANCE Graft: No patency modification AVF: Qa decrease thrombosis No patency modification No Doppler Studies Qa < 500mL/min + EF (+): SIMILAR to ONLY SURVEILLANCE Qa mL/min + Δ Qa > 25%: S: 92-95%, VPP79-86%) BETTER!!! All Qa cut-offs, separately, have similar VPP to EF and lower than DU. The increase in the cut-off remains controversial, once care increases without any clear benefit and even with potential harm (PTA of stable subclinical stenoses). Cohort: 50 patients Qa determination using vs BTM and its capability of diagnosing hemodynamically significant stenosis. NOTE: hemodynamically significant stenosis: reduction vessel lumen> 50% + increase in PSR of more than 2x (PSR in stenosis> 400 cm/s) ASDIN

3 4. Monitoring and Surveillance Chapters 1. Pre-surgical phase 2. VA Creation 3. VA Care New Spanish Guideline on Vascular Access Monitoring and surveillance 5. Complications treatment 6. Catheter 7. Quality indicators Centro Cochrane Iberoamericano Iberoamerican Cochrane Centre Can Doppler, performed by an experienced examiner, replace fistulography as the gold standard for confirming a diagnosis of significant stenosis in VA? Sensitivity 89.3 % (IC 95%: %) Specificity 94.7 % (IC 95 %: %) Meta-analysis made by the Iberoamerican Cochrane group which included 755 patients in 4 studies over the last 10 years, of which 319 were diagnosed with significant stenosis by fistulography (prevalence: 42.3%). Sensitivity of Doppler ruled against fistulography for diagnosis confirmation of significant VA stenosis in patients with clinical suspicion of stenosis: 89,3 % (IC 95%: 84,7-92,6 %). (MetaAnalyst Program, ). Meta-analysis made by the Iberoamerican Cochrane group, which included 755 patients in 4 studies over the last 10 years, of which 319 were diagnosed with significant stenosis by fistulography (prevalence: 42.3%). Specificity of Doppler ruled against fistulography for diagnosis confirmation of significant VA stenosis in patients with clinical suspicion of stenosis: 94.7% (95% CI: 91.8 to 96.6%). (MetaAnalyst Program, ). PREVALENCE SIGNIFICANT STENOSIS (%) Positive predictive value (%) Positive and negative predictive values of the according to the prevalence of significant stenosis Monitoring and Surveillance Can Doppler, performed by an experienced examiner, replace fistulography as the gold standard for confirming a diagnosis of significant stenosis in VA? R 4.2) Ultrasound is recommended first for image exploration in the hands of an experienced examiner, thereby eliminating the need for confirming via fistulography, to indicate elective treatment when significant stenosis is suspected. Negative predictive value (%) Accuracy (%) It is recommended that fistulography be reserved for diagnostic image exploration only in cases where results are non-conclusive and there is a persistent suspicion of significant stenosis. As positive predictive value of Doppler, i.e. the percentage of patients actually presenting significant stenosis among those diagnosed by Doppler, progressively increases, so does prevalence of clinicalsuspicionof significantstenosis among patients. Prevalence of significant stenosis: 50 % positive predictive value of the Doppler : 94.4% and this percentageincreases as higher prevalencesare reached. ASDIN

4 4. Monitoring and Surveillance 4. Monitoring and Surveillance R. 4.6) It is recommended using both first and second generation methods for monitoring and surveillance AVFn. GEMAV advises the periodical application of second-generation screening methods (both dilutional techniques to estimate blood flow or Qa and Doppler ) to surveil the AVFn, because existing evidence indicates a beneficial effect and there are no arguments against these methods in relation to thrombosis prediction and the increase in AVFn patency. GLOSSARY (III) Significant VA stenosis according to current or valid criteria Presence of a repeated alteration of any parameter obtained by the first- or second-generation screening methods, associated with a reduction lower than 50% of AVFn or AVFp vascular lumen proved by an imaging technique (colour Doppler or fistulography). GLOSSARY (IV) SignificantVA stenosis accordingto the criteria proposed by the new GEMAV Reduction in the vascular lumen higher than 50% shown by colour Doppler in AVFn and AVFp with a high risk of thrombosis according to the criteria set out in Chapter 4, i.e. dependent on elective or preventive treatment. º 5. Complications treatment R 5.1.1) In the absence of any contraindication, it is recommended that all stenoses with a vascular lumen reduction equal to or higher than 50% and that fulfil stenosis criteria related to high-risk of thrombosis be treated. R 5.1.2) It is recommended that fistulography be performed when central venous stenosis is suspected. Concept in nephrology: Not only flow screening In situ Image control Stenosis Masses and collections Confusing or alternative collaterals Treatment prioritization Flow criteria Seriousness of stenosis: risk of thrombosis Dangerous masses: pseudoaneurisms Treatment orientation Interventionist Surgical Conservative -guided puncture Deep AVF or difficult to puncture Pathological AVF waiting for treatment Objectives Present results after creation of a Vascular Access Program based on the use of by nephrology in a multidisciplinary approach, in: Pre-surgical Mapping Early stenosis diagnosis Preventive treatment Hemodialysis incidence of patients by AVF J. Ibeas, J. Vallespin, X. Vinuesa, et al Ecografia bajo protocolo en el accesovascular del pacienteen hemodialisis: del mapeo al seguimiento. Estudio de 500 casos Nefrología, 2012 (32), Sup. 3, 71 ASDIN

5 Our Center Follow Protocol Vascular Access Creation Referrals VA request Surgeon Visit Visit Image - Indication Surgical Indication Surgery Process times Ultrasound at joint nephrology/vascular surgery outpatient visit 150 patients 500,000 inhabitants Reference Center: - Interventional Radiology - Vascular Surgery Screening Alarm Process times Vascular Access Follow Up Surgeon Visit Image In Situ Ultrasound - Orientation Surgical Indication Surgery Radiological Confirmation Decision Interventional Treatment Treatment Protocol Surveillance Clinical Protocol Confirmation Dynamic Mapping Surgery Pre - HD HD Follow up Morphological Functional Analysis Portable Mapping Surgery Pre - HD HD Follow up Morphological Functional Diagnosis Decision Priorization Ultrasound Angiography Treatment Screening No Pathology Treatment Screening Alarms Alarms Morphological Study Anatomical trajectory Artery Anastomosis Vein Subclavia Stenosis % reduction of lumen Thrombosis Masses and collections Haematomas Abscesses Venous dilations Pseudoaneurisms Seromas Steal Anatomical anomalies Flow Functional study Better dysfunctionpredictor Grafts: measurementof the whole access AVF: measurementin vein and artery Artery: Better measurement in artery? Artery measurement: how much is QA underestimated Vein measurement: Difficult because of curves, bifurcations, variations in diameter, turbulence An advantage to guide the puncture efficiently? Flow measurement Shape of Doppler wave Patrick Wiese and Barbara Nonnast-Daniel. ColourDoppler ultrasound in dialysis access. Nephrol Dial Transplant, : ASDIN

6 Results AVF: n = 506, 3 Studies: 1. indicated for high or low level alarm: n= Study of Systematic Mapping vs. Physical Examination: n=247 Mapping + Surveillance: n=166 Only physical examination: n=81 3. Study of VA type on beginning HD by surgery prioritization: n=357 Age: 64.8 ± 15 years and Sex: 58% m, 42 % f Charlson Index: 7.8 Patency, total sample (n=506) Primary Assisted Patency: 1, 2 and 3 years: 74, 70 and 67 %. Maturation failure: 20% Immediate failure: 12% Tasa Thrombosis / patient / year Study by alarm of high and low level Alarm from high to low level 230 Vascular Access application reason 2% 46% 2% 7% Punction difficulty Qb VP Hemostasia Mixed Difficulties in Puncture 91% QB 50.6% VP 49.35% Hemostasis 27.27% 43% 2. Study Mapping + Surveillance group: 166 Mapping + surveillance Control group: 81 ASDIN

7 Mapping Vs phys.exam (n=247) Mapping: Age > 75 years Physical exam. Physical exam. Mapping: > 75 years + radial artery Total Sample (n=506): Sex Physical Exam. Female Male group (n=166). Sex 3. Study of VA type on beginning HD Results (n = 450) New VA n = 372 (82%) VA Patients Female Male Reconstruction n = 64 (15%) Surgical Recovery (n= 64) 59 reanastomosis Bridge VA n=14 (3%) In Hemodialysis = 38 Pre HD = 21 5 reconstruction (In HD) ASDIN

8 2/18/2015 J Ibeas, J Vallespin, JR Fortuño, et al. Reduction in waiting time for vascular access surgery following an computerized algorithm of clinical priorities gets 80% of starting hemodialysis by native fistula and 80% of fistula reparations on patients in hemodialysis without requirement of catheter. XLVIII ERA-EDTA Congress. Praga, June 2011 Priorities Distribution 1 00% 9 0% 1 26 (19%) 11 (17%) 112 (81%) 53 (83%) Catheter AVF 13 (93%) 8 0% 7 0% 6 0% 5 0% 4 0% 3 0% 2 0% 1 0% 0% Pre -HD In ic io HD HD Rea n a s t AVPu en te Conclusions Ultrasound used in Nephrology Services makes good use of the multidisciplinary team by providing the nephrologist and the nursing staff with decision-making ability in: Mapping Early diagnosis Treatment -guided puncture It can reduce morbility in patients with high comorbility. It should be part of the arsenal in the hands of nephrology services and learning how to use it should be included in training plans in the speciality. ASDIN

9 ASDIN

Introduction. Introduction 2/3/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life

Introduction. Introduction 2/3/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life Introduction Vascular Access complications: Ultrasound Evaluation of the Mature AVF and Process Improvement High associated morbi-mortality Worsened quality of life Up to 2 % hospitalized Jose Ibeas M.D.,

More information

Doppler Ultrasound: is it a third generation AVF surveillance method?

Doppler Ultrasound: is it a third generation AVF surveillance method? Doppler Ultrasound: is it a third generation AVF surveillance method? Jose Ibeas. Servei de Nefrologia Parc Tauli Sabadell, Hospital Universitari Barcelona Disclosures I have the following potential conflicts

More information

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance Hemodialysis Access Surveillance Postoperative AV Fistula Evaluation Failure of maturation Stenosis Perigraft mass/fluid collection Joseph L. Mills, Sr., M.D. Professor of Surgery Chief, Division of Vascular

More information

April 5-6, 2016 Sabadell, Barcelona

April 5-6, 2016 Sabadell, Barcelona V EDITION OF THE THEORETICAL AND PRACTICAL WORKSHOP FOR V EDITION OF THE THEORETICAL AND PRACTICAL WORKSHOP FOR UPDATE IN ULTRASOUND AND MULTIDISCIPLINARY APPROACH FOR VASCULAR ACCESS April 5-6, 2016 Sabadell,

More information

IN ARTERIOVENOUS FISTULA FAILURE

IN ARTERIOVENOUS FISTULA FAILURE DRUG ELUTING BALLOON ANGIOPLASTY IN ARTERIOVENOUS FISTULA FAILURE Nicola Troisi, MD GUIDELINES GUIDELINES VAS 2007 GUIDELINES VAS 2007 GUIDELINES VAS 2007 GUIDELINES VAS 2007 2007!!!!!!!!!! GUIDELINES

More information

on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach

on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach VII HANDS-ON HANDS SKILLS TRAINING WORKSHOP IN VASCULAR ACCESS: VI Hands-on on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach May 8-10, 2017 Sabadell, Barcelona With Support

More information

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS DISCLOSURES UTILITY OF ULTRASOUND IN EVALUATING ACCESS DYSFUNCTION None Vandana Dua Niyyar, MD Assistant Professor of Medicine, Division of Nephrology, Emory University UTILITY OF ULTRASOUND IN ACCESS

More information

AMMAR SERAWAN, MD. Ain Wzain Hospital. April 21, 2012 Vascular Access Study Workshop

AMMAR SERAWAN, MD. Ain Wzain Hospital. April 21, 2012 Vascular Access Study Workshop AMMAR SERAWAN, MD Ain Wzain Hospital April 21, 2012 Vascular Access Study Workshop 1 Inspection for signs of: - infection (redness, discharge, edema) -aneurysms (may be cannulated using the lateral side

More information

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University

More information

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley Approximately 45% of AVF are functional without intervention after creation The procedure rate is 1.45-3.3 procedures/avf

More information

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce

More information

Selection of Permanent Hemodialysis Vascular Access

Selection of Permanent Hemodialysis Vascular Access Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements

More information

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Button hole or Ladder?? Vascular Access Cannulation It s a Life Line of Hemodialysis patient Arterio-venous fistula(avf) is the K/DOQI

More information

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters

More information

Explorations fonctionnelles des abords vasculaires pour hémodialyse

Explorations fonctionnelles des abords vasculaires pour hémodialyse Explorations fonctionnelles des abords vasculaires pour hémodialyse Frank Le Roy Nephrology Department Actualités Néphrologiques Jean Hamburger Necker, 27 avril 2015 1966 Brescia, Cimino, Appel, Hurwich.

More information

Doppler ultrasound role in the evolution and evaluation of the complications of vascular hemodyalisis access.

Doppler ultrasound role in the evolution and evaluation of the complications of vascular hemodyalisis access. Doppler ultrasound role in the evolution and evaluation of the complications of vascular hemodyalisis access. Poster No.: C-1675 Congress: ECR 2015 Type: Educational Exhibit Authors: M. E. Banegas Illescas,

More information

Case Endovascular management of non maturing dyalisis vascular access

Case Endovascular management of non maturing dyalisis vascular access Case 10238 Endovascular management of non maturing dyalisis vascular access Guedes Pinto 1, Erique; Madeira 2, Célia; Sousa 3, Marta; Penha 1, Diana; Rosa 1, Luís; Germano 1, Ana; Baptista 1, Manuela 1

More information

Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?

Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier? Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier? Plan the Work Work the Plan What is a plan? A method for achieving an end An orderly arrangement of parts

More information

Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV

Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV Carlo Basile Division of Nephrology and Dialysis Miulli General Hospital, Acquaviva delle Fonti, Italy VASCULAR ACCESS

More information

Goals. Access flow and renal artery stenosis evaluation by Doppler ultrasound. Reimbursement. WHY use of Doppler Ultrasound

Goals. Access flow and renal artery stenosis evaluation by Doppler ultrasound. Reimbursement. WHY use of Doppler Ultrasound Access flow and renal artery stenosis evaluation by Doppler ultrasound Adina Voiculescu, MD Interventional Nephrology Brigham and Women s Hospital Boston Instructor at Harvard Medical School Understand

More information

Ultrasound and the dialysis patient

Ultrasound and the dialysis patient Ultrasound and the dialysis patient Poster No.: C-1765 Congress: ECR 2011 Type: Educational Exhibit Authors: T. M. O. Couto, H. Matos, Â. Moreira, A. Estevao ; vila conde/ 1 2 2 2 1 2, Coimbra/ Keywords:

More information

HANDBOOK ON ULTRASOUND FOR VASCULAR ACCESS EXAMINATION

HANDBOOK ON ULTRASOUND FOR VASCULAR ACCESS EXAMINATION HANDBOOK ON ULTRASOUND FOR VASCULAR ACCESS EXAMINATION From the Specialist to the Nurse Editors Rubén Iglesias Joaquím Vallespín José Ibeas HANDBOOK ON ULTRASOUND FOR VASCULAR ACCESS EXAMINATION From

More information

Supera for the Juxta-anastomotic AVF Stenosis

Supera for the Juxta-anastomotic AVF Stenosis Supera for the Juxta-anastomotic AVF Stenosis Dr Shannon D. Thomas Vascular Access Surgeon Conjoint Senior Lecturer University of New South Wales Sydney, Australia Disclosure Speaker name: Dr S. D. Thomas...

More information

Medical Director/Surgeon as Partners WebEx February 11, 2010

Medical Director/Surgeon as Partners WebEx February 11, 2010 Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances

More information

Evaluation of hemodialysis arteriovenous fistula before and after surgery: Teaching points

Evaluation of hemodialysis arteriovenous fistula before and after surgery: Teaching points Evaluation of hemodialysis arteriovenous fistula before and after surgery: Teaching points Poster No.: C-0625 Congress: ECR 2014 Type: Educational Exhibit Authors: L. C. C. Chierighini, P. C. Francolin,

More information

HD Scanning: Velocities and Volume Flow

HD Scanning: Velocities and Volume Flow HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year

More information

Distal Hypoperfusion Ischemic Syndrome (DHIS)

Distal Hypoperfusion Ischemic Syndrome (DHIS) Pathophysiology Traditional View ( Steal Syndrome ) Distal Hypoperfusion Ischemic Syndrome (DHIS) Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School

More information

The Art of Angioplasty

The Art of Angioplasty The Art of Angioplasty Achieving and Defining Success Thomas M. Vesely, MD Saint Louis, Missouri Dr. Vesely is a consultant for: W.L. Gore & Associates Lutonix Imaging the Vascular Access Circuit A well

More information

MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai

MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa,

More information

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC Background Endovascular AVF Outline Data from FLEX and NEAT study SPH data Clinical experience Cannulation

More information

Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography

Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography Keiji Tabuchi,2, Toshio Kobayashi 2, Junko Kumagai 3, Naoko Takahashi 3 ) Departments of Nursing, Omachi

More information

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose Local elastase to aid fistula maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2013 UCSF Vascular Symposium I have nothing to disclose AVF Prevalence 60.6% (April 2012) Fistula First Initiative

More information

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate

More information

ASDIN 7th Annual Scientific Meeting

ASDIN 7th Annual Scientific Meeting Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of

More information

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Poster No.: C-3355 Congress: ECR 2010 Type: Scientific Exhibit Topic: Interventional

More information

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty Unraveling the -59 modifier Principles of Interventional Coding Donald Schon, MD, FACP Debra Lawson, CPC, PCS Distinct or independent from other services performed on the same day Normally not reported

More information

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Richard Shoenfeld MD, FSIR, FAHA The Access Center at West Orange West Orange, New Jersey USA SEDAV 2015 Madrid November

More information

Preservation of Veins and Timing for Vascular Access

Preservation of Veins and Timing for Vascular Access Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access

More information

Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?

Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo,

More information

Regardless of whether you are a vascular surgeon,

Regardless of whether you are a vascular surgeon, C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless

More information

Thoughtful vs. Dogmatic

Thoughtful vs. Dogmatic Debate on Balloon Assisted Maturation The Biology is Wrong: BAM Won t Work BAM Dr. Rapp Debate BIVF Dr. Lawson Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical

More information

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your

More information

Vascular Access Options for Apheresis Medicine

Vascular Access Options for Apheresis Medicine Vascular Access Options for Apheresis Medicine Josh King, MD Divisions of Nephrology and Medical Toxicology University of Virginia September 21, 2018 Disclosure I have no personal or professional financial

More information

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations Vascular access for Dialysis a surgeon s perspective e. some observations Age of New Haemodialysis Patients 2005 Australia Number (Total=1957) 0.7% 3% 5% 10% 15% 20% 26% 19% 2% 0-14 15-24 25-34 35-44

More information

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting Fistula First "Unassisted" evaluation of access dysfunction (eyes, ears, and fingers) Tushar Vachharajani, MD Chief, Nephrology Section W. G. (Bill) Hefner VAMC Salisbury, NC Quality improvement projects

More information

Vascular Access Study Overview and Implementation

Vascular Access Study Overview and Implementation Vascular Access Study Overview and Implementation Salim Kabalan, MD Co-Principal Investigator Hafez Elzein, MD, MS Managing Director April 21, 2012 Investigator Meeting & Workshop Introduction Majority

More information

Jimmy Wei Hwa Tan, Surg, MD

Jimmy Wei Hwa Tan, Surg, MD Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following

More information

Does cannulation technique impact arteriovenous fistula and graft survival? Maria Teresa Parisotto CANNT 2017 Halifax October 20 th, 2017

Does cannulation technique impact arteriovenous fistula and graft survival? Maria Teresa Parisotto CANNT 2017 Halifax October 20 th, 2017 Does cannulation technique impact arteriovenous fistula and graft survival? Maria Teresa Parisotto CANNT 2017 Halifax October 20 th, 2017 Survival Preserving the AVF as the patient lifeline: reduced mortality

More information

Department of Vascular Surgery, Maastricht University, Maastricht - The Netherlands 2

Department of Vascular Surgery, Maastricht University, Maastricht - The Netherlands 2 The Journal of Vascular Access 2007; 8: 281-286 ORIGINAL ARTICLE Accessory veins and radial-cephalic arteriovenous fistula non-maturation: a prospective analysis using contrast-enhanced magnetic resonance

More information

Physician Clinical Experiences with FIR Therapy in the UK and Taiwan

Physician Clinical Experiences with FIR Therapy in the UK and Taiwan ENGLAND 1. Source: Moore I 1, Adam JH, Sweeney D, et al. (2011). Far infrared (FIR) therapy An effective treatment for AV fistula maturation and maintenance. J Am Soc Nephrol 2011; 22: 564A (Poster FR-PO1947).

More information

The Gold Standard. ASDIN 2014 Scientific Meeting. When is an AVF mature? Longitudinal Assessment of AVF Maturation with Ultrasound.

The Gold Standard. ASDIN 2014 Scientific Meeting. When is an AVF mature? Longitudinal Assessment of AVF Maturation with Ultrasound. Wen is an AVF mature? Longitudinal Assessment of AVF Maturation wit Ultrasound CONFLICT of INTEREST DECLARATION St Micael s Hospital olds patent on use of ig frequency probes for evaluation of venous structures

More information

JMSCR Vol 04 Issue 11 Page November 2016

JMSCR Vol 04 Issue 11 Page November 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i11.21 Assessment of Vein Intima-Media Thickness

More information

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts

More information

Simulations of the blood flow in the arterio-venous fistula for haemodialysis

Simulations of the blood flow in the arterio-venous fistula for haemodialysis Acta of Bioengineering and Biomechanics Vol. 16, No. 1, 2014 Original paper DOI: 10.5277/abb140109 Simulations of the blood flow in the arterio-venous fistula for haemodialysis DANIEL JODKO*, DAMIAN OBIDOWSKI,

More information

Il paziente anziano, evidenza e survey nazionale

Il paziente anziano, evidenza e survey nazionale Università La Sapienza Scuola di Specializzazione in Nefrologia Prof P. Menè Meeting di Nefrololgia Interventistica L Accesso Vascolare Impossibile Roma 23 Marzo 2016 Il paziente anziano, evidenza e survey

More information

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of

More information

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3

More information

Int J Adv Med. For your questions please send message to

Int J Adv Med. For your questions please send message to Int J Adv Med SPECTRUM OF VASCULAR ABNORMALITIES IN COLOR DOPPLER EXAMINATION OF UPPER EXTREMITIES TESTED FOR SUITABLITY FOR AV FISTULA CREATION IN PATIENTS OF RENAL FAILURE. Journal Name : International

More information

Cannulation Techniques Webinar

Cannulation Techniques Webinar Cannulation Techniques Webinar March 28, 2012 ESRD Network of Texas Lynda K. Ball, MSN, RN, CNN Objectives Discuss assessment skills inspection, palpation, and auscultation of an AV fistula to determine

More information

Tale of Neglected Aneurysm

Tale of Neglected Aneurysm Disclosures Tale of Neglected Aneurysm Consultant to FFCL Tushar Vachharajani, MD, FASN Chief, Nephrology Section Salisbury VAMC, NC Objectives How do you define Aneurysm? When and How do you treat? Defining

More information

Hemodialysis Fistula Maturation Consortium

Hemodialysis Fistula Maturation Consortium Hemodialysis Fistula Maturation Consortium Rationale for Fistula Maturation Study Dialysis Access Consortium AVF study 60% of new AVFs were unusable for dialysis at 4-5 months post surgery No predictors

More information

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System Percutaneous AV Fistula Creation Ellipsys EndoAVF System Presented by Forest Rawls Jr CHT,CCHT-A,FNKF No Disclosures Various Access Types Some old Some new Scribner Shunt OUR OLD DEPENDABLE FRIEND

More information

Recurrent lesions in AV access & Initial DCB experience in India

Recurrent lesions in AV access & Initial DCB experience in India Recurrent lesions in AV access & Initial DCB experience in India Dr. Virender K Sheorain Consultant Interventional Radiologist Medanta-The Medicity Hospital Gurgaon, INDIA Disclosure Speaker name:... I

More information

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following

More information

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access Vascular and Interventional Radiology Review Shenoy and Darcy Ultrasound in Dialysis Interventions Vascular and Interventional Radiology Review FOUS ON: Surendra Shenoy 1 Michael Darcy 2 Shenoy S, Darcy

More information

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr

More information

Sonographic Evaluation of an Immature Brescia-Cimino Fistula

Sonographic Evaluation of an Immature Brescia-Cimino Fistula 696792JDMXXX10.1177/8756479317696792Journal of Diagnostic Medical SonographyChappell research-article2017 Case Study Sonographic Evaluation of an Immature Brescia-Cimino Fistula Journal of Diagnostic Medical

More information

Pitfalls in pushing fistulas ----

Pitfalls in pushing fistulas ---- Pitfalls in pushing fistulas ---- An argument for more grafts Marc Webb, MD, FACS Michigan Vascular Access, PC March 27 th, 2009 Vascular Access for Hemodialysis ------- Basic facts - the need for Access

More information

Developing a Quality Assurance Performance Improvement (QAPI) Program at Your Dialysis Center Rudolph P. Valentini, M.D. Associate Professor of Pediatrics Director of Dialysis Services Vice Chief of Staff

More information

Disclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest

Disclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest Disclosure Speaker name: Prof. Hesham Aly Sharaf El-Din I do not have any potential conflict of interest Introduction 5% of patients with upper limb AVF develop ipsilateral hand ischemia, recently termed

More information

Percutaneous and Surgical Treatments

Percutaneous and Surgical Treatments AVG Pseudoaneurysms Percutaneous and Surgical Treatments Marius Florescu M.D. Feb. 2015 ASDIN DEFINITION AVG Pseudoaneurysm Formation Incidence AVG Pseudoaneurysm incidence rate ranges between 2% and 10%

More information

DETECT-PAD Computerized and patient specific model to determine pressure gradients in borderline iliac artery stenosis with MRA/ CTA

DETECT-PAD Computerized and patient specific model to determine pressure gradients in borderline iliac artery stenosis with MRA/ CTA DETECT-PAD Computerized and patient specific model to determine pressure gradients in borderline iliac artery stenosis with MRA/ CTA Jean-Paul P.M. de Vries Head Department of Surgery University Medical

More information

VFI Technology to Change the Way You Work

VFI Technology to Change the Way You Work Analogic Ultrasound VFI Technology to Change the Way You Work Vascular Ultrasound Made Easier Vector Flow Imaging VFI VFI is a ground-breaking technology that can revolutionize the workflow for many Doppler

More information

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National

More information

Drug-eluting balloon for the treatment of failing hemodialytic arteriovenous fistulas

Drug-eluting balloon for the treatment of failing hemodialytic arteriovenous fistulas Drug-eluting balloon for the treatment of failing hemodialytic arteriovenous fistulas Poster No.: C-0216 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Exhibit M. B. Cilda#, K. Köseo#lu; Ayd#n/TR

More information

VASCULAR ACCESS SYMPOSIUM

VASCULAR ACCESS SYMPOSIUM SYMPOSIUM INFORMATION Important symposium dates: Online registration opens June 3, 2013 Abstract submission opens September 1, 2013 Deadline for abstract submission January 19, 2014 Notification of acceptance/rejection

More information

ASDIN 8th Annual Scientific Meeting

ASDIN 8th Annual Scientific Meeting Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure

More information

Vector Volume Flow in Arteriovenous Fistulas

Vector Volume Flow in Arteriovenous Fistulas Downloaded from orbit.dtu.dk on: Apr 25, 2018 Vector Volume Flow in Arteriovenous Fistulas Hansen, Peter Møller; Heerwagen, Søren; Pedersen, Mads Møller; Rix, Marianne; Lönn, Lars; Nielsen, Michael Bachmann;

More information

Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter

Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter The guidelines for arteriovenous access intervention, management and abandonment,

More information

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access From the Society for Clinical Vascular Surgery Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access Robert B. McLafferty, MD, Raymond W. Pryor

More information

TheSensitivityandSpecificityofClinicalExaminationoftheHemodialysisArterialVenousFistulaAVFasComparedtoAngiography

TheSensitivityandSpecificityofClinicalExaminationoftheHemodialysisArterialVenousFistulaAVFasComparedtoAngiography : F Diseases Volume 16 Issue 3 Version 1.0 Year 2016 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN: 0975-5888

More information

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients

More information

JVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE

JVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,

More information

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -

More information

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What

More information

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi Stage 5 Chronic Kidney Disease Assessing the Results of AV Access: Realistic Outcomes in 2009 Sean P. Roddy, MD Albany, NY Defined as a GFR

More information

Surgical Options in Thrombectomy for Non-Surgeons

Surgical Options in Thrombectomy for Non-Surgeons Surgical Options in Thrombectomy for Non-Surgeons Shouwen Wang, MD, PhD, FASDIN AKDHC Ambulatory Surgery Center Arizona Kidney Disease and Hypertension Center Phoenix, Arizona Disclosure No relevant financial

More information

Background. Background. Background. Curriculum Design and Editorial Process. Creating a PD Curriculum. ASDIN HVA Core Curriculum

Background. Background. Background. Curriculum Design and Editorial Process. Creating a PD Curriculum. ASDIN HVA Core Curriculum Background Creating a PD Curriculum Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School The scope of our current practice as a new subspecialty within

More information

Proven Performance Through Innovative Design *

Proven Performance Through Innovative Design * Proven Performance Through Innovative Design * Deliver Our Next Generation AV Covered Stent Results The COVERA Vascular Covered Stent builds upon proven technologies from the category leader in AV Access.

More information

Nursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN

Nursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN Nursing Care of the Dialysis Patient Adrian Hordon, MSN, RN Understand principles of hemodialysis Recognize different access ports Identify side effects and complications Discuss nursing care for pre and

More information

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB Andrew Holden Auckland Hospital Auckland, New Zealand LINC 2017 26 th January 2017 Disclosure Speaker name: Andrew Holden I have

More information

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas AV ACESS COMPLICATIONS Ass. Prof. Dr. Habas COMPLICATION AVF IS CONSIDERED A MINOR PROCEDURE INCIDENCE OF COMPLICATION- 20-27% MANY A COMPLICATION LEADS TO FAILURE OF FISTULA LOSS OF SITE AND VEIN FOR

More information

Colour Doppler ultrasound in dialysis access

Colour Doppler ultrasound in dialysis access 1956 Nephrol Dial Transplant (2004) 19: Editorial Comments Nephrol Dial Transplant (2004) 19: 1956 1963 DOI: 10.1093/ndt/gfh244 Advance Access publication 15 June 2004 Colour Doppler ultrasound in dialysis

More information

Creation of primary arteriovenous fistula:vascular access for hemodialysis

Creation of primary arteriovenous fistula:vascular access for hemodialysis Interventional Cardiology Creation of primary arteriovenous fistula:vascular access for hemodialysis Sustainable vascular access (VA) is literally a lifeline for most end-stage renal disease (ESRD) patients

More information

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center The HeRO Graft Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center Faculty Disclosure I disclose the following financial relationships: CryoLife/Hemosphere, Inc. & W.L. Gore and

More information

Arteriovenous Graft Modeling and Hemodynamic Interpretation

Arteriovenous Graft Modeling and Hemodynamic Interpretation Open Journal of Fluid Dynamics, 2012, 2, 324-330 http://dx.doi.org/10.4236/ojfd.2012.24a040 Published Online December 2012 (http://www.scirp.org/journal/ojfd) Arteriovenous Graft Modeling and Hemodynamic

More information

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system Hemodialysis International 2019 Original Article Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system Hedia HEBIBI, 1,2,3 Jedjiga

More information

Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS

Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS Assistant Professor of Surgery Vascular Endovascular Surgery Louisiana State University Health - Shreveport Disclosures None Objective

More information

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD The views presented reflect those of the author/presenter and do not necessarily reflect those of ASDIN nor serve as an endorsement of safety, efficacy or applicability of said procedure. the Endovascular

More information